Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
about
Atypical antipsychotics in bipolar disorder: systematic review of randomised trialsRisperidone alone or in combination for acute maniaHaloperidol alone or in combination for acute maniaA critical appraisal of treatments for bipolar disorderPublication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorderAmisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trialReport of three cases that received maintenance treatment with risperidone as a mood stabilizerThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmAcute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy.The psychopathology and treatment of bipolar disorder.Combination therapy for manic phases: a critical review of a common practice.Pharmacokinetics of aripiprazole and concomitant lithium and valproate.The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder.Treating bipolar disorder. Evidence-based guidelines for family medicine.[Anticonvulsants and antipsychotics in the treatment of bipolar disorder].Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BDThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?Pharmacotherapy of first-episode psychosis.Atypical antipsychotics in the treatment of bipolar disorder.Combination treatment in bipolar disorder: a review of controlled trials.Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.Acute and long-term treatment of mania.Effect of initial ziprasidone dose on treatment outcome of korean patients with acute manic or mixed episodes.Recent developments in the treatment of bipolar disorders.Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics.Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management.New medication treatment options for bipolar disorders.Latest therapies for bipolar disorder. Looking beyond lithium.Valproate in bipolar disorder: 2000 onwards.Bipolar mixed states and their treatment.Risperidone for bipolar disorders.Pharmacotherapy of bipolar mixed states.Atypical antipsychotics: newer options for mania and maintenance therapy.Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.Higher than Physician's Desk Reference (US) doses on atypical antipsychotics.Safety and tolerability of emerging pharmacological treatments for bipolar disorder.The safety and tolerability of atypical antipsychotics in bipolar disorder.Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders.
P2860
Q21260276-0112DE3A-0485-48FD-AAD9-76C1A07FD704Q24244719-2D4D440F-C218-4FC9-BE47-DF3C31269A71Q24245158-E5593A44-BC33-4E58-BC9C-495921A6803BQ24613657-E1535481-AD88-4202-B6B1-4A98F0DA2EB6Q24643545-89A5DB8F-FDC5-4B8F-B6ED-9ECB34F7D11DQ24656287-FB7D36BD-6B78-495C-B615-CE5440C5DB52Q24791405-94D217FD-49B1-43C2-8B55-6E13802B52B2Q28066714-28CAD2F0-F1F1-4F94-B22F-C54AD6695133Q33268080-DCA75893-C572-401A-B237-204435C5AFE5Q33619910-237D00C9-E7D5-4207-A3A6-EF245214B117Q34308027-B356E736-234E-48D6-B059-3F586E13150EQ34376865-1390C66C-3319-4C9B-A09D-B0D4884B672EQ34531273-A1C783D9-7932-436B-AD62-14C89D8D1C60Q34547920-DD6C1BA3-238E-4C69-A021-979941A2F09CQ34550254-68E180C9-C6E8-4504-BAD1-B41ED537D64EQ34553398-79BBDABA-950A-4869-AE57-12A16ECC56E9Q34575982-68581512-1015-45B1-B041-066914A65BD1Q34606256-C7272F92-B771-4D11-8AEE-F64288B81C09Q34809427-196531D3-65AB-412E-BE1A-F89458876DD0Q35124708-EF1D24E3-9B3D-4CF1-B106-E37688862679Q35124712-03248D6F-26C3-4395-A212-5C0EB0D615FFQ35142745-3DFB64B7-2B40-4FCB-8B23-1A9EDAEF600AQ35180787-0D87D979-FC50-4AD5-8402-661562243C7DQ35236966-DEF2A4C9-346F-4EA1-9D9A-E90BF9277A92Q35238333-CCA4240A-8318-4D89-A6CE-AB9A44BE442FQ35547289-58900C9E-F6A5-4E36-A7B6-A7F7FFE57C73Q35618427-D5BA1E2E-538A-4C95-B604-447A30D1D312Q35618441-C2AB351F-36E3-4A7F-B0D5-48ED37A4F892Q35872066-F8437993-DF58-4BE8-95B0-94CC7AFD831EQ36060748-7B17CA42-2AAA-4755-B216-FA8185622A92Q36099536-6B142E00-035E-4C3E-9869-1C793480CFDAQ36106765-981AD229-3D98-4067-8C42-A50D4D8719D7Q36106798-9B5566DE-D069-486E-9530-435B775D0CA6Q36130303-BC106372-431E-45DF-9F35-4DF1C520EDB3Q36158824-26AAEF2D-DB81-4936-BE62-EC62021D0B11Q36162402-CE062DA3-8F4A-4E37-886B-99C1CEA895F1Q36191013-B23AF7DE-1DE3-499F-B6DB-EF9044B77EE8Q36199036-E79E248E-0FCA-49B7-8549-B043CBD168B7Q36235502-85F8DD37-6D5C-47B4-84EB-81BF1495CF33Q36272473-7C7872D4-949E-4F0B-BF84-EB72F279A43F
P2860
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Combination of a mood stabiliz ...... arison of efficacy and safety.
@en
Combination of a mood stabiliz ...... arison of efficacy and safety.
@nl
type
label
Combination of a mood stabiliz ...... arison of efficacy and safety.
@en
Combination of a mood stabiliz ...... arison of efficacy and safety.
@nl
prefLabel
Combination of a mood stabiliz ...... arison of efficacy and safety.
@en
Combination of a mood stabiliz ...... arison of efficacy and safety.
@nl
P2093
P1476
Combination of a mood stabiliz ...... arison of efficacy and safety.
@en
P2093
Akiko Okamoto
Charles L Bowden
Fred Grossman
Gary S Sachs
S Nassir Ghaemi
P304
P356
10.1176/APPI.AJP.159.7.1146
P407
P577
2002-07-01T00:00:00Z